ViroVet is a dynamic and innovative brand that offers cutting-edge products and services in the field of animal health. Comprised of a talented team, ViroVet has made significant strides in the industry, with a successful acquisition and the merging of livestock assets and Academia's groundbreaking innovations. Currently boasting a team of nearly 20 full-time experts, ViroVet's dedication to excellence has been recognized by Animal Pharm News, naming them the startup of the year in both 2015 and 2017.

To further experience the impact of ViroVet, you can connect with their esteemed board members, founders, and investors. The board of directors, chaired by George Gunn and led by CEO Erwin Blomsma, represents a diverse range of expertise and experience. The brand's investors, including AIF, Seventure Partners, PMV, and more, contribute to ViroVet's continued success.

With an emphasis on collaboration and innovation, ViroVet is at the forefront of animal health, driven by a passion for improving the well-being of animals worldwide. Copyright © ViroVet NV 2023. All rights reserved